Resveratrol Supplementation Did Not Improve Cognition in Patients with Schizophrenia
Results from a Randomized Clinical Trial
Bibliographic Data
| ID | 15519286 |
|---|---|
| Authors | Karine Zortéa (0000-0001-9595-6619, Hospital de Clínicas de Porto Alegre, corresponding author), Viviane Carvalho Franco (Universidade Federal do Rio Grande do Sul), Paula Guimarães (0000-0002-2197-1004), Paula Tavares Guimarães (Universidade Federal do Rio Grande do Sul), Paulo Belmonte‐de‐Abreu (0000-0002-2853-2004, Hospital de Clínicas de Porto Alegre), Paulo S Belmonte-de-Abreu |
| Year | 2016 |
| Volume | 7 |
| Pages | 159-159 |
| Publication date | 2016-09-16 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2016.00159 |
| PMID | 27695423 |
| OpenAlex | W2520613751 |
| Language | EN |
| Citations received | 1 |
| References cited | 14 |
In conclusion, we have shown that 1 month of a resveratrol supplementation (200 mg/day) did not improve episodic memory, working memory, attention and concentration capacity, inhibitory control, interference measures, selective attention, and mental flexibility as compared with placebo in patients with SZ
Cambridge Neuropsychological Test Automated Battery · Cognition · Cognitive flexibility · Effects of sleep deprivation on cognitive performance · Episodic memory · Placebo · Psychiatry · Psychopathology · Randomized controlled trial · Schizophrenia (object-oriented programming · Spatial memory · Stroop effect · Working memory · Adenosine and Purinergic Signaling · Clinical Psychology · Medicine · Psychology · Sirtuins and Resveratrol in Medicine · Tryptophan and brain disorders · Internal Medicine
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,2 |
| Citation span | 2021 - 2021 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |